Last reviewed · How we verify
NCT05712213
sIPOM vs pIPOM in Incisional Hernia Patients
trial testing Intraperitoneal onlay mesh reinforcement with defect closure before placement of mesh (pIPOM) in Incisional Hernia in 187 participants. Completed in 30 June 2022.
30 June 2022
Quick facts
| Lead sponsor | University of Campania Luigi Vanvitelli |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 187 |
| Start date | 1 January 2015 |
| Primary completion | 30 June 2022 |
| Estimated completion | 30 June 2022 |
Drugs / interventions tested
- Intraperitoneal onlay mesh reinforcement with defect closure before placement of mesh (pIPOM)
- Standard intraperitoneal onlay mesh repair (sIPOM)
Conditions studied
- Incisional Hernia — all drugs for Incisional Hernia →
Sponsor
University of Campania Luigi Vanvitelli
Who can join
Adults 18 to 65, any sex, with Incisional Hernia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Nowadays, two intraperitoneal mesh approaches are commonly used in Laparoscopic Ventral Hernia Repair (LVHR): the simple intraperitoneal onlay mesh repair (sIPOM) and the intraperitoneal onlay mesh reinforcement with defect closure before placement of mesh (pIPOM). The pIPOM has been introduced to reduce adverse events in incisional hernia (IH) surgery (i.e., seroma formation, recurrences etc ) associated to laparoscopic hernia repair, and satisfactory outcomes has been reported in several studies. In details, sequelae such mesh bulging seems to be less associated to pIPOM than sIPOM, even if the latter topic is matter of intense debate. The pIPOM has been introduced in the guidelines for the laparoscopic treatment of ventral and incisional abdominal wall hernias published by the International Endohernia Society (IEHS) in 2014. Despite prospective studies on the quality of IPOM-Plus are available, the evidence level for the statements in these guidelines remains low. The aim of this prospective analysis is to compare the postoperative outcomes of patients treated for Incisional hernia (IH) with sIPOM and pIPOM after 36 months follow-up in terms of recurrence and wound events.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
IPOM plus versus IPOM standard in incisional hernia repair: results of a prospective multicenter trial.
Pizza F, D'Antonio D, Lucido FS, Brusciano L, et al · · 2023 · cited 10× · PMID 37149818 · DOI 10.1007/s10029-023-02802-2
Verify or expand the search:
- PubMed search for NCT05712213
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Incisional Hernia
Currently open trials in the same condition.
- NCT06762561 — Prophylactic Mesh Reinforcement After Open Aortic Aneurysm Repair · recruiting
- NCT06499324 — Surgery with Botulinum Toxin a for Incisional Hernia · Phase 3 · recruiting
- NCT06220058 — Comparing Polypropylene Mesh and "Small Bites" Technique in Emergency Colorectal Surgery's Midline Laparotomy Closure. S · NA · recruiting
- NCT05596357 — Incisional heRnia dIgestion Sexuality · recruiting
Other University of Campania Luigi Vanvitelli trials
Trials by the same sponsor.
- NCT07590349 — Personalized Robotic Telerehabilitation for Upper Limb Functional Recovery After Stroke in a Home-Based Setting · NA · not yet recruiting
- NCT06718452 — Tinnitus and Treatment With umPEA-LUT · NA · not yet recruiting
- NCT07124676 — Prospective Study Comparing Two Classification Systems for Second-degree Vaginal Tears During Spontaneous Childbirth to · not yet recruiting
- NCT07425912 — Real-World Evaluation of TouchCare Nano in Pediatric Type 1 Diabetes · active not recruiting
- NCT06991816 — The Brain&Senses Study · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05712213 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Campania Luigi Vanvitelli
- Last refreshed: 6 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05712213.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing